NACUITY PHARMACEUTICALS, INC.

Profile

Company Names

NACUITY PHARMACEUTICALS, INC.

Addresses

FORT WORTH CLUB BLDG., 306 W. 7TH STREET, SUITE 310, FORT WORTH, TX 76102

Phone Numbers

817-336-3000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$31,219,350.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-12-11 
$8,393,350.00 
$30,000,000.00 
$21,606,650.00 
Equity, Debt 
3
2021-03-16 
$11,626,000.00 
$17,400,000.00 
$5,774,000.00 
Equity 
2
2017-06-15 
$9,227,000.00 
$10,000,000.00 
$773,000.00 
Equity 
1
2016-11-08 
$1,973,000.00 
$2,500,000.00 
$527,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DR. GERALD 
D. 
CAGLE 
DIRECTOR
RICHARD 
 
CHIN, M.D. 
DIRECTOR
HALDEN 
 
CONNER 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
HALDEN 
CONNER 
EXECUTIVE OFFICER, DIRECTOR
EMMETT 
 
CUNNINGHAM, JR. 
DIRECTOR
SANFORD 
J. 
HILLSBERG 
DIRECTOR
RUSTY 
 
KELLEY 
DIRECTOR
JAMI 
 
KERN 
EXECUTIVE OFFICER
CHARLES 
 
LIESER 
EXECUTIVE OFFICER
ROBIN 
 
STEEL 
DIRECTOR
MICHAEL 
 
WALL 
EXECUTIVE OFFICER
G. 
MICHAEL 
WALL, PH.D. 
EXECUTIVE OFFICER
DAVID 
 
WOHLBERG 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
J. 
WOHLBERG 
DIRECTOR
BENJAMIN 
 
YERXA 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2025-12-11 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-16 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-15 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MAXIM GROUP LLC
CLIFFORD ADAM TELLER
MAXIM GROUP LLC